Injection kit: Tirzepatide 5 mg vial + 2 ml Sodium Chloride 0.9% solvent vial
In stock — dispatch within 48h
❄️ Temperature-controlled delivery (2–8°C) across the EU.
BIOAMINO LABS Tirzepatide 5 mg Kit is an all-in-one preparation package containing 1 vial of lyophilized tirzepatide (5 mg) plus 1 dedicated vial of 2 ml sterile 0.9% Sodium Chloride Injection. This format removes the hassle of sourcing separate diluents and is perfectly scaled for initial tolerance trials (two 2.5 mg doses) or precise single 5.0 mg therapeutic administration.
Tirzepatide is a first-in-class dual glucose-dependent insulinotropic polypeptide (GIP) and glucagon-like peptide-1 (GLP-1) receptor agonist. By simultaneously activating both incretin pathways, it exerts synergistic metabolic control: promoting glucose-dependent insulin secretion from pancreatic beta cells, suppressing inappropriate glucagon release, slowing gastric motility, and stimulating central hypothalamic satiety circuits to curb appetite and enhance peripheral insulin sensitivity.
Transfer the 2 ml included NaCl solution into the tirzepatide vial. Swirl gently. The resulting solution yields 2.5 mg/ml (1.0 ml = 2.5 mg dose; entire 2.0 ml = 5.0 mg dose).
To ensure gastrointestinal tolerability, Tirzepatide administration must follow a stepwise escalation protocol. Treatment initiates at a low starting dose of 2.5 mg subcutaneously once weekly for the initial 4 weeks (adaptation phase). The dose is then increased to 5.0 mg once weekly. Subsequent increments of 2.5 mg may occur at minimum 4-week intervals based on clinical assessment and tolerance, up to the maximum dose of 15.0 mg weekly.
| Kit contents | 1 vial 5mg Tirzepatide + 1 vial 2ml NaCl 0.9% |
|---|---|
| Peptide dose | 5 mg |
| Included solvent | 2.0 mL Sodium Chloride 0.9% Injection |
| Reconstituted strength | 2.5 mg / mL (when mixed with 2 mL) |
| Manufacturer | Bioamino Labs |
| Storage | 2°C to 8°C (Protect from light) |
Store refrigerated at 2°C to 8°C (36°F to 46°F). Protect from direct light. Do not freeze. For pre-filled pens: once in use, the pen may be kept at room temperature (below 30°C / 86°F) for up to 21-28 days. For reconstituted vials: maintain in refrigerator at 2°C to 8°C and use sterile single-use syringes.
The kit includes the peptide vial and the solvent vial. Standard sterile insulin syringes (1 mL / 100 U) are recommended for administration.
